Key result
Injectable hydrogels promote post-infarction cardiac repair by providing structural support and targeted microenvironment modulation.
Why the study?
Myocardial infarction remains a major clinical challenge due to ischemic injury and adverse remodeling, highlighting the need to evaluate injectable hydrogels for post-infarction cardiac repair.
Do injectable hydrogels improve myocardial infarction repair and cardiac function in preclinical models?
Do injectable hydrogels improve myocardial infarction repair and cardiac function in preclinical models?
This review provides a comprehensive framework for the design and clinical translation of next-generation injectable hydrogels for myocardial infarction repair.
Answers are grounded in this paper and cite their sources.
Injectable hydrogels show preclinical promise for post-MI repair; leaves open clinical translation pending standardized efficacy trials.
Myocardial infarction remains a major clinical challenge because ischemic injury triggers inflammation, oxidative stress, cardiomyocyte loss, impaired vascularization, and adverse ventricular remodeling. Injectable hydrogels offer a minimally invasive and versatile strategy for post-infarction cardiac repair by providing structural support, localized bioactive delivery, and dynamic modulation of the injured myocardial microenvironment. This review highlights pathology-informed design principles for injectable hydrogels, including shear-thinning injectability, in situ gelation, tissue adhesion, modulus matching, fatigue resistance, biodegradability, and controlled bioactivity. We further discuss hydrogel-based strategies for immunomodulation, angiogenesis, fibrosis attenuation, extracellular matrix remodeling, and myocardial regeneration. Finally, translational progress and key challenges involving biosafety, scalable manufacturing, standardization and long-term efficacy are examined. This review provides a concise framework for developing next-generation injectable hydrogels for myocardial infarction repair and clinical translation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a review in Myocardial infarction. Injectable hydrogels was evaluated. Injectable hydrogels offer a minimally invasive strategy for post-infarction cardiac repair by providing structural support, localized bioactive delivery, and dynamic modulation of the injured myocardial microenvironment.
Synapse has enriched 10 related papers. Consider them for comparative context: